Cargando…

Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study

INTRODUCTION: The serotonin 5-HT(4) receptor agonist prucalopride is approved in the European Union for the treatment of chronic constipation. This offered the unique opportunity to include real-world observational data on cardiovascular safety in the new drug application for approval of prucaloprid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilsenan, Alicia, Fortuny, Joan, Cainzos-Achirica, Miguel, Cantero, Oscar F., Flynn, Robert W. V., Garcia-Rodriguez, Luis, Harding, Abenah, Kollhorst, Bianca, Karlsson, Pär, Linnér, Love, MacDonald, Thomas M., Odsbu, Ingvild, Plana, Estel, Ruigómez, Ana, Schink, Tania, Ziemiecki, Ryan, Andrews, Elizabeth B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739451/ https://www.ncbi.nlm.nih.gov/pubmed/31134512 http://dx.doi.org/10.1007/s40264-019-00835-0

Ejemplares similares

Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350
por: Fortuny, Joan, et al.
Publicado: (2019)

Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
por: Ruigómez, Ana, et al.
Publicado: (2021)

Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013)

Prucalopride: the evidence for its use in the treatment of chronic constipation
por: Coremans, Georges
Publicado: (2008)

Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
por: Nuijten, Mark J. C., et al.
Publicado: (2015)

Patient considerations in the management of chronic constipation: focus on prucalopride
por: Shin, Andrea
Publicado: (2016)

Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation
por: Tameez Ud Din, Asim, et al.
Publicado: (2019)

Development of a population pharmacokinetic model of prucalopride in children with functional constipation
por: van Schaick, Erno, et al.
Publicado: (2016)

Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review
por: Ali, Hassam, et al.
Publicado: (2021)

A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
por: Tack, Jan, et al.
Publicado: (2023)

Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians
por: Ke, M, et al.
Publicado: (2013)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
por: Sloots, Cornelius E. J., et al.
Publicado: (2010)

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials
por: Camilleri, Michael, et al.
Publicado: (2016)

Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
por: Yang, Tao, et al.
Publicado: (2021)

Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety
por: Hong, Ji Taek
Publicado: (2021)

Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating
por: Staller, Kyle, et al.
Publicado: (2022)

Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe
por: Fortuny, Joan, et al.
Publicado: (2021)

Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials
por: Sajid, Muhammad S, et al.
Publicado: (2016)

Antipsychotics induced constipation in patients with mental disorders. treatment suggestion with prucalopride in refractory cases. case report and literature review
por: Mpouras, P., et al.
Publicado: (2022)

Effect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trial
por: Liu, Baoyan, et al.
Publicado: (2014)

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
por: Ke, M, et al.
Publicado: (2012)

An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
por: Damodaran, Ishwary, et al.
Publicado: (2020)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies
por: Ke, MeiYun, et al.
Publicado: (2014)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015)

The Effects of Prucalopride on Postoperative Ileus in Guinea Pigs
por: Park, Soo Jung, et al.
Publicado: (2013)

Effects of prucalopride on esophageal secondary peristalsis in humans
por: Yi, Chih-Hsun, et al.
Publicado: (2016)

Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
por: Cuffari, Carmen, et al.
Publicado: (2023)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study
por: Thöne, Kathrin, et al.
Publicado: (2017)

Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
por: Nakitanda, Aya Olivia, et al.
Publicado: (2022)

Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study
por: Dehury, Suhasini, et al.
Publicado: (2023)

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2020)

Effects of Single-Dose Prucalopride on Intestinal Hypomotility in Horses: Preliminary Observations
por: Laus, Fulvio, et al.
Publicado: (2017)

Colon Capsule Visualization Is Not Enhanced with Prucalopride: A Randomized Controlled Trial
por: Hookey, Lawrence, et al.
Publicado: (2018)

Cardiovascular risk perception in women: true unawareness or risk miscalculation?
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2015)

A Reduction in Ribonucleotide Reductase Activity Slows Down the Chromosome Replication Fork but Does Not Change Its Localization
por: Odsbu, Ingvild, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3bcfsn2gbsgtg0fb1h5766m58o